abraham mohan

Rheumatologist

[TheLiverDoc™ @theliverdoc]

Ok I'm tired of this bullshit*t. But in any case, I'll indulge your sealioning nonsense.

Yes, people were "treated" in ancient times with herbs and roots and rituals. They also routinely died at age 30 from diarrhea, a scratched knee, or a tooth infection.

The argument that modern medicine is "overrated" because ancient people used "jadi buti" (herbs) relies on a spectacular cocktail of logical fallacies and errors in critical thinking.

Saying "people managed back then" completely ignores the astronomical infant death rates and the millions who died in agony from infections that a basic antibiotic cures today in 48 hours or a simple drug prevents complications of in this era. You are looking only at the lucky survivors, not the overflowing ancient graveyards. This is your Survivorship Bias.

The assumption that because something is old, it must be wise, effective, or true is common human stupidity. Bloodletting, drilling holes in skulls to release demons, and drinking mercury were also ancient medical traditions. Age is a measure of endurance, not of scientific validity. This is your Appeal to Antiquity Fallacy.

The romanticized notion that "natural herbs" are inherently safer than "chemical tablets" is an idiocy that never dies in the minds of alternative medicine sympathizers like yourself. Nature is not your friend; it is actively trying to kill you just like "all natural" Ayurveda is too.

When an ancient remedy passes rigorous scientific tests, it stops being "alternative medicine" and simply becomes medicine.

But when a traditional treatment fails these tests, a rational, scientific system discards it. A dogmatic business promoting system keeps selling it anyway, pointing to 2,000-year-old texts as "proof."

Also there is no modern Ayurveda. Ayurveda is, was, and always will be primitive medeival dmbfckery. Hope this was sensible enough. Please don't waste my time anymore.

[David Liew @drdavidliew]

EULAR FMF recommendations 2025:
still emphasis on colchicine adherence to maximal dose
+/- bDMARDs if needed for control
+/- csDMARDs for residual chronic MSK involvement

new: consider tapering bDMARD if remission >6mo

See the treatment algorithm below⬇️

#EULAR2025 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

FMF #Recommendations

#Colchicine can be fatal

🔺️Monitor regularly

#EULAR2025
@RheumNow

[Nelly ZIADE 🍀 @Nellziade]

FMF #Recommendations

🔺️Start Colchicine in All (& continue for confirmed pts)
🔺️Single or divided dose, depend on adherence & tolerance
🔺️Max dose 2 mg children, 3 mg adults
🔺️if failure: add IL1i (6 RCT) (2 for IL6i)
🔺️Add c or bDMARd if MSK

#EULAR2025
@RheumNow

[Nelly ZIADE 🍀 @Nellziade]

FMF #Recommendations

During attack:
🔺️No use of increasing Colchicine
🔺️No use for corticosteroids and opioid
🔺️Use NSAIDs

#EULAR2025
@RheumNow

[Adela Castro @AdelaCastro222]

Pearls on EGPA:
1. GC are mainstay for mild
dz
2. Organ threatening/relapsing➡️CYP (RTX alternative)
3. W/o organ threatening➡️ anti-IL-5/IL-5R.
4. IL5i are less effective for ENT
5. Consider sx for nasal polyps.

#EULAR2025 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

Is there an association btwn ⬆️ CRP & cardiovascular dysfunction in #axSpA?

🔹️245 pts
🔹️CRP recorded for past 5y
🔹️sustained high CRP in 40%
🔹️associated with ⬆️ cardiovascular risk factors, ⬇️endothelial function & subclin atheroslerosis

POS0714
#EULAR2025
@RheumNow

[Adela Castro @AdelaCastro222]

Management of AAV:
1.High dose GC f/b reduced dose taper ‼️caution in pts w/severe renal dz and RTX induction.
2. RTX effective for induction and maintenance, best for relapses.
3.PLEX: in RPGN pts if accesible ⚠️ risk for infection.
4.Avacopan: for faster GC weaning. No efficacy eval >1y.
#EULAR2025 @RheumNow

[Dr. John Cush @RheumNow]

Psoriatic Arthritis at Risk for Interstitial Lung Disease

A TriNetX EHR study shows that psoriatic arthritis (PsA), but not Psoriasis (PsO), patients are at increased risk for interstitial lung disease (ILD).

https://t.co/2zuxF1PY3Q.

[Janet Pope @Janetbirdope]

+RCT in #pSjD #Sjogrens #Disease

#Leflunomide + #hydroxychloroquine
Vs #PBO

2nd study to show this - same group

need to know
▶️what pt to use this in
▶️is there diff organ improvements

⬆️#ESSDAI
⬇️RF ⬇️Ig’s

Easy to prescribe
?early, mild dx
#EULAR2025 @RheumNow @eular_org

[abraham mohan @drabrahammohan]

Take a look at my article! https://t.co/N8o4CRx8kE

[abraham mohan @drabrahammohan]

Drug Induced Autoimmunity: Propylthiouracil Induced ANCA Vasculitis - Mohan - 2025 - International Journal of Rheumatic Diseases - Wiley Online Library https://t.co/x5hqpHbItG

[abraham mohan @drabrahammohan]

Take a look at my article! https://t.co/N8o4CRx8kE

[abraham mohan @drabrahammohan]

https://t.co/3zmUBexcTB
Clinically challenging scenarios sometimes require innovative approaches!
# Case report - Caritas hospital

[abraham mohan @drabrahammohan]

https://t.co/3zmUBexcTB
Clinically challenging scenarios sometimes require innovative approaches!
# Case report - Caritas hospital

[abraham mohan @drabrahammohan]

@TimesAlgebraIND You worked so hard to build your dream.why should they work so hard to build your dream?

[Vinod Ravindran @12VRavindran]

Enjoy the last issue of 2024 @IRAeNewsLetter (https://t.co/IWr7ixCFIW)

👉🏼 🦀Malignancies in Rheumatology
👉🏼 Perspectives on Gout and Nanomedicine 🤔
👉🏼 Quiz & reviews💡
👉🏼 Unmet needs in medical education? 📚
👉🏼 Politics! 😎

[abraham mohan @drabrahammohan]

https://t.co/aG7ZhFJRpm Image#Indian Rheumatology Association E-newsletter.

[Dr. John Cush @RheumNow]

RA Risk Radar: Heart Disease, Infection, and Malignancy

Rheumatologists Dr. Jeffery Curtis and Dr. Jon Giles discuss comorbidities that can occur as a consequence of uncontrolled inflammation in RA. Sponsored by AbbVie US Medical Affairs.
https://t.co/aTjwsqZCzt

[Dr. John Cush @RheumNow]

Exploring severe active cases of granulomatosis with polyangiitis (GPA) & microscopic polyangiitis (MPA). Two physician case reports offer critical insights. Sponsored by Amgen. https://t.co/hjLuYFqTGi